# MCM C Agent — Project & Collaboration Status

Updated: 2026-11-05. This page is a manually maintained status snapshot, **not a live dashboard**.

| Area | Status | Evidence / next gate |
| --- | --- | --- |
| Phase A: deterministic EDA | Implemented, visual review largely completed; residual metadata/export checks | `feature/m1a-data-eda`, Draft PR #1 |
| Phase B: Visual EDA planner | Implementation and CI exercised; user verified DeepSeek planning | `feature/m1b-visual-eda`, Draft PR #2; final milestone acceptance / merge still pending |
| Phase B: API Settings | Implemented and used locally; key remains session scoped | Same PR #2 |
| Multi-agent governance | Draft policies/templates on separate branch | Draft PR to `feature/m1b-visual-eda`, pending user approval |
| Cursor autonomous builder | Not connected by this governance PR | Owner authorization & pilot required |
| Claude Code independent review | Not connected by this governance PR | Owner authorization & pilot required |
| Grok QA | Optional; not connected | Deferred pending benefit/cost evaluation |
| Auto-merge, scheduled agents, protected branches | Not configured by governance documents | Admin/settings access and separate authorization required |

## Current next milestone
Establish a bounded **builder → reviewer → CI → decision package** pilot. Use a low-risk Issue, isolated branch and draft PR. Owner decides if actual external integrations should be installed and what permissions/cost limits to grant.

## Known cautions
- Passing `pytest -q` does not establish real LLM quality, contest correctness, UI reliability or production readiness.
- No generic "all agents working" claim until each integration is connected and independently verified.
- PR #2 is not automatically merged into `main`. Governance changes are isolated.
- The Google Docs PRD may not be synchronized automatically with GitHub; use an explicit synchronization action when available.

## Status updates required per milestone
Owner decision; scope completed; PR/CI references; reviewer name/model and outcome; failed cases; cost/privacy effects; next gate.
